News
Spring edition Venture Challenge starts in the summer
Six innovative teams were selected this spring to participate in the Venture Challenge, a coaching programme for start-ups in the Life Sciences & Health that is being organised for the first time under the auspices of
Venture Challenge alumnus Predica Diagnostics is supported by the RedMedtech Discovery Fund
May 8, 2020 RedMedTech Discovery Fund supports CervicaDx development
Corona bridging loan for startups, scale-ups likely available from end of April
Last Tuesday, April 7, the Dutch cabinet announced that it will initially make € 100 million available for bridging loans to start-ups, scale-ups and innovative SMEs that have been financially affected by the impact of the corona crisis.
Venture Challenge Alumnus AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)
Today we are reminded that antibiotics are an important part of treatment regiments not only for severe antiviral infections, such as COVID-19, but also other hospitalized patients with multidrug-resistant (MDR) secondary infections
AGILeBiotics appoints new CEO Victor Schut
Victor Schut has been appointed as the new Chief Executive Officer (CEO) of AGILeBiotics and co-founder Dr. Andreas A. Bastian has now taken on the role of Chief Operating Officer (COO).
Six teams selected for the Venture Challenge Spring 2020 - Workshops postponed due to COVID-19 restrictions
Six teams have been selected by NWO for participation in the Venture Challenge Spring 2020 edition.
Venture Challenge Alumnus Toxys Raises €2 Million Financing for Global Expansion of its Unique Animal-Free Chemical Safety Tests
Venture Challenge Alumnus Toxys is an innovative Dutch biotech company that develops unique animal-free labo
Prolira - Delirium awareness day
Early detection of delirium, quick intervention and good monitoring is of great importance to prevent (permanent) consequential damage.
Cyclomics and University Medical Center Utrecht sign collaboration agreement
Following the licensing of liquid biopsy technology owned by the University Medical Center Utrecht (UMC Utrecht), Cyclomics and the UMC Utrecht have entered into a long-standing collaboration to strengthen the synergy between both parties f